Antiem Bui, DO
Nephrology · Lakewood
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 12 years
- Arizona College of Osteopathic Medicine Mid Western University, 2014
Offices
3 locations · Southland Renal Medical Group Inc · 8 clinicians in this group
Hospitals listed: 052724 · 552532 · 552639 · 552821 · 552858 · Memorialcare Long Beach Medical Center · Pih Health Downey Hospital · Pih Health Good Samaritan Hospital · Pih Health Hospital-Whittier · Uci Health-Lakewood · 05t471. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bui’s office at (562) 630-3111 to ask if they take your plan before you enroll.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Memorialcare Long Beach Medical CenterLong Beach, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of MemorialCare Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.505, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.596, Oct 2024 – Sep 2025
- Pih Health Downey HospitalDowney, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of PIH Health, which runs 3 hospitalsPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
- Pih Health Good Samaritan HospitalLos Angeles, CAAcute Care Hospital · Proprietary · No emergency department · Birthing-friendlyPart of PIH Health, which runs 3 hospitalsPatients rate it 2 of 5 · 68% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Postoperative respiratory failure rate: 17.38 (10.02 to 24.75) · 381 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.175, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.345, Oct 2024 – Sep 2025
- Pih Health Hospital-WhittierWhittier, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of PIH Health, which runs 3 hospitalsPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.497, Oct 2024 – Sep 2025
- Uci Health-LakewoodLakewood, CAAcute Care Hospital · Proprietary · Has an emergency departmentPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 1 of 5 · 48% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.105, Oct 2024 – Sep 2025
See every measure and the patient survey for Memorialcare Long Beach Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.505 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.596 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0.06 to 1.95) · 1,454 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.8 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 203.2 (163.37 to 243.02) · 113 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 76 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 272 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 247 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 411 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 3,352 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.3 (0.1 to 0.5) · 5,922 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 6,111 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.51 (1.59 to 5.44) · 1,808 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.46 (0.92 to 4.01) · 745 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.58 to 3.41) · 1,658 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.23 (7.34 to 19.12) · 790 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.78 (3.38 to 10.19) · 786 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.92 (0.46 to 3.38) · 474 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.86) · 5,287 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 7.4 · 72 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.834 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.27 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.975 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.394 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 227 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 559 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 30.7 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -7.8 · 318 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 8 · 261 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.4 to 7.2) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.9 (9.8 to 16.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 68 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 204 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.8 to 17.8) · 75 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 374 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,188 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Pih Health Downey Hospital
Behind the star rating — Deaths: 1 better, 5 the same, 0 worse of 6 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.28 (0.21 to 2.34) · 403 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.44 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 178 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.9 · 201 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.1 · 160 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 2,052 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,633 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,714 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (0.61 to 5.59) · 276 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.51 to 3.87) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.89 (0 to 18.8) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.46) · 25 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 63 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.22) · 2,012 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.198 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 124 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.1 · 614 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.7 · 229 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16.5 · 234 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 495 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.3 to 16.8) · 432 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 156 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,108 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Pih Health Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative respiratory failure rateComplications and deaths | 17.38 (10.02 to 24.75) · 381 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.175 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.345 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0 to 2.02) · 577 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.13 (0.79 to 1.48) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.85 (117.01 to 216.68) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.1 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 75 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 246 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.1 · 248 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.2 · 147 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 2,024 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 4,499 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.48) · 4,631 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.4 (1.11 to 5.69) · 961 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.96 (0.3 to 3.61) · 335 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.35 (0.82 to 3.89) · 934 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.89 (2.87 to 10.9) · 375 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 129 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.92) · 3,336 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 98 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.685 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.861 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.168 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 143 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 52.9 · 73 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 49.3 · 319 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 55.9 · 275 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.4 · 400 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 48 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.9 · 97 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.2 to 16.9) · 138 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 191 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,234 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 50% |
| Yes, staff "did" give patients this information | 78% |
| Yes, staff "did" give patients information about help after discharge | 75% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 64% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 37% |
| Yes, staff "did" give patients information about possible symptoms | 81% |
See every measure and the patient survey for Pih Health Hospital-Whittier
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.497 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.83 (0 to 1.8) · 1,222 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.77 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.59 (122.43 to 208.75) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 64 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 323 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 360 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 553 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 4,869 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,090 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 6,261 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.56 (3.44 to 7.67) · 1,178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.98 (0.31 to 3.64) · 255 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.28 (1.77 to 4.79) · 1,113 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.32 (5.89 to 20.76) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.43 to 9.49) · 249 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.16 to 3.11) · 236 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.12 (0 to 0.71) · 5,179 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 140 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.594 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.825 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.474 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.445 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.39 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 509 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 1,125 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.1 · 147 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27 · 401 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 30.4 · 400 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 1,019 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.3 to 7.4) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (10.4 to 18.1) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7 · 140 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 222 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (10.1 to 16.6) · 1,770 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 397 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,178 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Uci Health-Lakewood
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.105 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.94 (0 to 1.97) · 512 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.15 (0.77 to 1.53) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.76 (139.14 to 246.38) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 57 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 56 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.2 · 264 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.5 · 223 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 1,866 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.07 to 0.51) · 3,098 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,262 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.72 (1.33 to 6.11) · 498 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.91 (1.29 to 4.53) · 492 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.25 (1.53 to 20.97) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.91 (0.24 to 1.58) · 2,875 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 89 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.584 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.498 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.265 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 181 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 403 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.3 · 56 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 32.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 89.6 · 289 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 495 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 96 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12 · 70 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.5 to 17.5) · 95 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 80 cases | No different | Jan 2024 – Dec 2024 |
What patients said (391 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 1 |
| Quietness | 1 |
| Recommend hospital | 1 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 66% |
| Doctors "always" communicated well | 68% |
| Staff "always" explained | 50% |
| Yes, staff "did" give patients this information | 79% |
| Yes, staff "did" give patients information about help after discharge | 78% |
| Doctors "always" explained things so they could understand | 62% |
| Doctors "always" listened carefully | 67% |
| Doctors "always" treated them with courtesy and respect | 75% |
| Patients who gave a rating of "9" or "10" (high) | 49% |
| Staff "always" explained new medications | 63% |
| Nurses "always" explained things so they could understand | 60% |
| Nurses "always" listened carefully | 64% |
| Nurses "always" treated them with courtesy and respect | 73% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 48% |
| Staff "always" explained possible side effects | 36% |
| Yes, staff "did" give patients information about possible symptoms | 80% |
Original Medicare doctor bills
$266,277
Medicare paid this office $266,277 for 455 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 53 | $69,536 | $301 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 161 | $54,157 | $101 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 61 | $50,024 | $253 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 121 | $23,211 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 129 | $21,018 | $146 |
See all 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 53 | $69,536 | $301 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 161 | $54,157 | $101 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 61 | $50,024 | $253 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 121 | $23,211 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 129 | $21,018 | $146 |
| Dialysis services, 1 physician visit per month (20 years or older) | 44 | $13,996 | $177 |
| Short return visit (20+ min) | 103 | $10,543 | $78 |
| Return visit (30+ min) | 62 | $6,143 | $89 |
| Hemodialysis procedure with physician evaluation | 43 | $4,115 | $61 |
| New patient visit (30+ min) | 46 | $3,497 | $76 |
Who their Medicare patients are
455 Original Medicare patients in 2024. Average age 69 · Under 65 28% · 85 and older 13% · Women 50% · Also on Medicaid 79% · Health risk score 5.56. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 73% · Heart failure 56% · Coronary heart disease 46% · Atrial fibrillation 31% · Depression 31% · COPD 28% · Stroke 25% · Dementia 21% · Cancer 15%.
The office billed $789,326, Medicare allowed $338,226 and paid $266,277; for 1,901 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 455 | 1,901 | 69 | 5.56 | $789,326 | $266,277 |
| 2023 | 405 | 1,681 | 70 | 5.16 | $636,460 | $245,740 |
| 2022 | 397 | 1,576 | 70 | 4.90 | $604,410 | $237,079 |
| 2021 | 425 | 1,797 | 70 | 4.44 | $666,030 | $271,881 |
| 2020 | 368 | 1,795 | 70 | 5.25 | $575,010 | $227,175 |
| 2019 | 110 | 268 | 67 | 6.62 | $93,315 | $36,638 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 42 | $72,281 | $302 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 183 | $63,706 | $101 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 49 | $30,956 | $254 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 119 | $19,481 | $149 |
| Home dialysis services per month (20 years or older) | 13 | $17,993 | $253 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 74 | $12,415 | $67 |
| Return visit (30+ min) | 87 | $12,210 | $97 |
| Dialysis services, 1 physician visit per month (20 years or older) | 19 | $7,203 | $176 |
| Hemodialysis procedure with physician evaluation | 32 | $3,055 | $61 |
| New patient visit (30+ min) | 20 | $1,913 | $96 |
| Short return visit (20+ min) | 32 | $1,906 | $58 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,205 | $100 |
2022: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 56 | $88,894 | $310 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 144 | $42,366 | $87 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 44 | $27,126 | $258 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 87 | $17,014 | $170 |
| Return visit (30+ min) | 96 | $16,858 | $103 |
| Short return visit (20+ min) | 104 | $8,014 | $70 |
| Dialysis services, 1 physician visit per month (20 years or older) | 21 | $7,723 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $7,435 | $61 |
| Hemodialysis procedure with physician evaluation | 33 | $3,445 | $63 |
| New patient visit (30+ min) | 17 | $1,429 | $84 |
2021: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 52 | $114,652 | $307 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 157 | $52,837 | $88 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 40 | $26,582 | $258 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 111 | $23,418 | $170 |
| Short return visit (20+ min) | 143 | $13,798 | $72 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $10,388 | $61 |
| Return visit (30+ min) | 39 | $5,812 | $110 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $3,740 | $178 |
| New patient visit (30+ min) | 35 | $3,193 | $91 |
| Hemodialysis procedure with physician evaluation | 23 | $1,877 | $63 |
2020: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 185 | $62,126 | $90 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 47 | $51,448 | $246 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 61 | $34,086 | $209 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 135 | $26,991 | $172 |
| Dialysis services, 1 physician visit per month (20 years or older) | 45 | $19,087 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 111 | $17,013 | $62 |
| Home dialysis services per month (20 years or older) | 11 | $6,813 | $200 |
| Short return visit (20+ min) | 61 | $5,952 | $61 |
| New patient visit (30+ min) | 29 | $2,401 | $83 |
| Hemodialysis procedure with physician evaluation | 12 | $1,087 | $64 |
2019: 6 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 27 | $11,199 | $243 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $7,403 | $88 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 26 | $6,354 | $205 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,486 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,343 | $62 |
| New patient visit (30+ min) | 18 | $1,697 | $94 |
Medicaid work
$41,007 in 2024
Medicaid paid $41,007 for 1,380 billed services this clinician did in 2024, up to 35 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 160 | $13,845 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 147 | $9,593 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 452 | $6,757 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 225 | $3,035 |
| 1ST HOSP IP/OBS HIGH 75 | 97 | $2,606 |
| Short return visit (20+ min) | 188 | $2,289 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 25 | $1,346 |
| Return visit (30+ min) | 72 | $921 |
| New patient visit (30+ min) | 14 | $616 |
| 2024 | 1,380 | 9 | 35 | $41,007 |
| 2023 | 1,696 | 8 | 40 | $78,323 |
| 2022 | 1,241 | 5 | 39 | $57,381 |
| 2021 | 1,046 | 6 | 39 | $47,587 |
| 2020 | 342 | 6 | 19 | $17,536 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 216 | $25,430 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 736 | $24,198 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 182 | $15,498 |
| Return visit (30+ min) | 311 | $5,631 |
| 1ST HOSP IP/OBS HIGH 75 | 78 | $3,366 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 68 | $1,619 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 13 | $1,380 |
| Short return visit (20+ min) | 92 | $1,202 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 266 | $36,594 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 367 | $9,416 |
| Return visit (30+ min) | 319 | $6,489 |
| Short return visit (20+ min) | 276 | $3,306 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 13 | $1,576 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 224 | $28,966 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 480 | $13,253 |
| Short return visit (20+ min) | 223 | $2,633 |
| 1ST HOSP IP/OBS HIGH 75 | 17 | $1,121 |
| Return visit (30+ min) | 73 | $920 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 29 | $695 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 193 | $6,141 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 24 | $3,771 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 27 | $3,688 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 58 | $1,893 |
| 1ST HOSP IP/OBS HIGH 75 | 28 | $1,252 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 12 | $790 |
Drugs they prescribed that Part D paid
$395,250
Pharmacies billed $395,250 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,537) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
1,155 generic and 382 brand-name prescriptions · $395,250 in drug cost · 21 antibiotic prescriptions to 20 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 109 | $95,513 | $876 |
| Velphoro | 16 | $52,873 | $3,305 |
| Jardiance | 21 | $28,790 | $1,371 |
| Veltassa | 40 | $27,728 | $693 |
| Lokelma | 22 | $21,593 | $981 |
See all 37 drugs
| Farxiga | 109 | $95,513 | $876 |
| Velphoro | 16 | $52,873 | $3,305 |
| Jardiance | 21 | $28,790 | $1,371 |
| Veltassa | 40 | $27,728 | $693 |
| Lokelma | 22 | $21,593 | $981 |
| Dapagliflozin | 36 | $19,437 | $540 |
| Sevelamer | 12 | $15,879 | $1,323 |
| Januvia | 12 | $14,942 | $1,245 |
| Auryxia | 12 | $14,836 | $1,236 |
| Lanthanum Carbonate | 12 | $10,892 | $908 |
| Tradjenta | 13 | $8,170 | $628 |
| Sevelamer Carbonate | 37 | $5,847 | $158 |
| Procrit | 12 | $5,415 | $451 |
| Nifedipine Er | 35 | $1,602 | $46 |
| Furosemide | 202 | $1,098 | $5 |
| Bumetanide | 16 | $974 | $61 |
| Metoprolol | 59 | $905 | $15 |
| Calcium Acetate | 16 | $807 | $50 |
| Metolazone | 13 | $625 | $48 |
| Losartan | 75 | $452 | $6 |
| Amlodipine Besylate | 118 | $451 | $4 |
| Hydralazine | 51 | $335 | $7 |
| Potassium Chloride | 20 | $293 | $15 |
| Gentamicin Sulfate | 12 | $284 | $24 |
| Carvedilol | 55 | $244 | $4 |
| Tamsulosin | 30 | $244 | $8 |
| Lisinopril | 51 | $223 | $4 |
| Allopurinol | 30 | $202 | $7 |
| Calcitriol | 12 | $198 | $16 |
| Benazepril | 18 | $141 | $8 |
| Pantoprazole | 12 | $126 | $11 |
| Atorvastatin | 21 | $121 | $6 |
| Clonidine | 12 | $84 | $7 |
| Hydrochlorothiazide | 16 | $70 | $4 |
| Gabapentin | 17 | $48 | $3 |
| Ropinirole | 12 | $33 | $3 |
| Glipizide | 12 | $7 | $1 |
Year by year
| 2024 | 1,537 | 341 | 0% (0) | 25% | $395,250 |
| 2023 | 1,148 | 287 | None | None | $260,261 |
| 2022 | 1,322 | 298 | None | None | $303,537 |
| 2021 | 1,474 | 315 | 0% (0) | None | $316,606 |
| 2020 | 983 | 252 | None | None | $237,997 |
| 2019 | 308 | 120 | 0% (0) | None | $85,136 |
| 2018 | 196 | 65 | None | 20% | $49,175 |
| 2017 | 598 | 28 | 4% (22) | None | $69,953 |
| 2016 | 375 | 32 | 5% (20) | None | $50,551 |
| 2015 | 56 | None | None | None | $4,698 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Farxiga | 65 | $65,143 | $1,002 |
| Auryxia | 17 | $25,079 | $1,475 |
| Lokelma | 19 | $22,718 | $1,196 |
| Veltassa | 25 | $16,693 | $668 |
| Sevelamer Carbonate | 35 | $16,632 | $475 |
| Januvia | 12 | $7,061 | $588 |
| Nifedipine Er | 46 | $3,702 | $80 |
| Calcium Acetate | 12 | $1,539 | $128 |
| Hydralazine | 59 | $1,499 | $25 |
| Furosemide | 142 | $1,479 | $10 |
| Amlodipine Besylate | 95 | $1,394 | $15 |
| Losartan | 66 | $1,266 | $19 |
| Carvedilol | 49 | $961 | $20 |
| Tamsulosin | 35 | $879 | $25 |
| Midodrine | 12 | $737 | $61 |
| Lisinopril | 61 | $652 | $11 |
| Metoprolol | 19 | $434 | $23 |
| Benazepril | 18 | $293 | $16 |
| Allopurinol | 20 | $283 | $14 |
| Potassium Chloride | 11 | $269 | $24 |
| Gabapentin | 15 | $134 | $9 |
| Glipizide | 13 | $18 | $1 |
2022: 32 drugs
| Renvela | 21 | $46,133 | $2,197 |
| Velphoro | 13 | $45,185 | $3,476 |
| Sevelamer Carbonate | 47 | $23,912 | $509 |
| Veltassa | 24 | $22,606 | $942 |
| Farxiga | 16 | $16,476 | $1,030 |
| Auryxia | 12 | $16,246 | $1,354 |
| Tradjenta | 15 | $14,451 | $963 |
| Cinacalcet | 12 | $5,313 | $443 |
| Calcium Acetate | 24 | $3,972 | $165 |
| Nifedipine Er | 88 | $3,945 | $45 |
| Retacrit | 12 | $2,613 | $218 |
| Furosemide | 170 | $1,412 | $8 |
| Hydralazine | 46 | $1,277 | $28 |
| Metoprolol | 53 | $1,097 | $21 |
| Calcitriol | 33 | $866 | $26 |
| Losartan | 68 | $861 | $13 |
| Metolazone | 11 | $800 | $73 |
| Carvedilol | 54 | $751 | $14 |
| Amlodipine Besylate | 101 | $730 | $7 |
| Gentamicin Sulfate | 12 | $530 | $44 |
| Lisinopril | 57 | $478 | $8 |
| Lactulose | 15 | $450 | $30 |
| Allopurinol | 38 | $379 | $10 |
| Valsartan | 11 | $361 | $33 |
| Tamsulosin | 19 | $341 | $18 |
| Metoprolol | 28 | $233 | $8 |
| Prednisone | 11 | $195 | $18 |
| Pantoprazole | 12 | $193 | $16 |
| Atenolol | 13 | $171 | $13 |
| Benazepril | 12 | $159 | $13 |
| Omeprazole | 13 | $105 | $8 |
| Hydrochlorothiazide | 11 | $48 | $4 |
2021: 25 drugs
| Velphoro | 17 | $70,824 | $4,166 |
| Sevelamer Carbonate | 83 | $43,352 | $522 |
| Veltassa | 33 | $38,305 | $1,161 |
| Lokelma | 37 | $31,094 | $840 |
| Januvia | 21 | $19,875 | $946 |
| Procrit | 11 | $6,537 | $594 |
| Calcium Acetate | 31 | $4,154 | $134 |
| Nifedipine Er | 78 | $3,484 | $45 |
| Metoprolol | 72 | $1,467 | $20 |
| Losartan | 120 | $1,435 | $12 |
| Furosemide | 197 | $1,406 | $7 |
| Calcitriol | 49 | $1,356 | $28 |
| Hydralazine | 54 | $1,035 | $19 |
| Amlodipine Besylate | 112 | $753 | $7 |
| Allopurinol | 64 | $581 | $9 |
| Lisinopril | 67 | $403 | $6 |
| Tamsulosin | 14 | $261 | $19 |
| Nitrofurantoin Mono-Macro | 14 | $226 | $16 |
| Benazepril | 26 | $190 | $7 |
| Metoprolol | 25 | $177 | $7 |
| Chlorthalidone | 13 | $147 | $11 |
| Clonidine | 12 | $144 | $12 |
| Atenolol | 11 | $136 | $12 |
| Carvedilol | 17 | $123 | $7 |
| Ciprofloxacin | 12 | $57 | $5 |
2020: 23 drugs
| Velphoro | 11 | $39,841 | $3,622 |
| Procrit | 25 | $30,669 | $1,227 |
| Sevelamer Carbonate | 39 | $22,552 | $578 |
| Lokelma | 20 | $16,088 | $804 |
| Eliquis | 11 | $6,554 | $596 |
| Retacrit | 13 | $3,771 | $290 |
| Nifedipine Er | 51 | $1,682 | $33 |
| Calcium Acetate | 18 | $1,579 | $88 |
| Losartan | 69 | $1,201 | $17 |
| Hydralazine | 55 | $1,098 | $20 |
| Furosemide | 126 | $845 | $7 |
| Calcitriol | 26 | $577 | $22 |
| Metoprolol | 22 | $407 | $18 |
| Carvedilol | 30 | $401 | $13 |
| Amlodipine Besylate | 49 | $396 | $8 |
| Allopurinol | 34 | $353 | $10 |
| Lisinopril | 35 | $256 | $7 |
| Potassium Chloride | 12 | $236 | $20 |
| Tamsulosin | 15 | $132 | $9 |
| Clonidine | 11 | $131 | $12 |
| Gabapentin | 13 | $108 | $8 |
| Metoprolol | 11 | $88 | $8 |
| Ciprofloxacin | 18 | $59 | $3 |
2019: 8 drugs
| Velphoro | 19 | $43,141 | $2,271 |
| Nifedipine Er | 15 | $676 | $45 |
| Calcitriol | 13 | $371 | $29 |
| Carvedilol | 16 | $217 | $14 |
| Losartan | 16 | $206 | $13 |
| Lisinopril | 21 | $175 | $8 |
| Furosemide | 27 | $113 | $4 |
| Amlodipine Besylate | 16 | $98 | $6 |
2018: 4 drugs
| Sevelamer Carbonate | 17 | $13,919 | $819 |
| Losartan | 13 | $111 | $9 |
| Carvedilol | 11 | $67 | $6 |
| Metoprolol | 11 | $67 | $6 |
2017: 19 drugs
| Tradjenta | 13 | $4,994 | $384 |
| Spiriva | 11 | $4,049 | $368 |
| Ventolin Hfa | 12 | $639 | $53 |
| Metoprolol | 15 | $604 | $40 |
| Gabapentin | 21 | $515 | $25 |
| Hydralazine | 21 | $404 | $19 |
| Levothyroxine | 24 | $391 | $16 |
| Pravastatin | 24 | $298 | $12 |
| Metformin | 33 | $232 | $7 |
| Lisinopril | 32 | $122 | $4 |
| Furosemide | 18 | $119 | $7 |
| Allopurinol | 17 | $93 | $5 |
| Clonidine | 13 | $88 | $7 |
| Tramadol | 19 | $81 | $4 |
| Sertraline | 14 | $66 | $5 |
| Clopidogrel | 11 | $61 | $6 |
| Pantoprazole | 12 | $60 | $5 |
| Glipizide | 20 | $59 | $3 |
| Metoprolol | 12 | $49 | $4 |
2016: 8 drugs
| Levothyroxine | 37 | $625 | $17 |
| Gabapentin | 19 | $403 | $21 |
| Atorvastatin | 17 | $298 | $18 |
| Tramadol | 18 | $68 | $4 |
| Metformin | 14 | $66 | $5 |
| Lisinopril | 13 | $37 | $3 |
| Glipizide | 11 | $32 | $3 |
| Simvastatin | 12 | $18 | $2 |
Money from drug and device companies
$723 in 2025
| 2025 | 6 | 19 | None | $723 |
| 2024 | 9 | 26 | None | $944 |
| 2023 | 4 | 17 | None | $691 |
| 2022 | 4 | 4 | None | $384 |
| 2021 | 4 | 10 | None | $636 |
| 2020 | 1 | 1 | None | $125 |
| 2019 | 4 | 4 | None | $399 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Aurinia Pharma U.S. | Lupkynis | $288 | 5 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $239 | 9 payments
|
| Calliditas Therapeutics US | Tarpeyo | $125 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $43 | 2 payments
|
| Novartis Pharmaceuticals | None | $27 | 1 payment
|
| Travere Therapeutics | Filspari | $2 | 1 payment
|
See all 19 published payments
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-07 | Kerendia | $28 |
| Aurinia Pharma U.S. | Meals · 2025-10-29 | Lupkynis | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-16 | Farxiga | $21 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-10 | Kerendia | $24 |
| Aurinia Pharma U.S. | Meals · 2025-09-18 | Lupkynis | $228 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-12 | Kerendia | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-14 | Farxiga | $22 |
| Aurinia Pharma U.S. | Meals · 2025-08-09 | Lupkynis | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-18 | Kerendia | $24 |
| Travere Therapeutics | Education · 2025-07-18 | Filspari | $2 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-06-06 | Kerendia | $29 |
| Novartis Pharmaceuticals | Meals · 2025-05-23 | None | $27 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-16 | Kerendia | $32 |
| Aurinia Pharma U.S. | Meals · 2025-04-19 | Lupkynis | $17 |
| Aurinia Pharma U.S. | Meals · 2025-04-17 | Lupkynis | $1 |
| Calliditas Therapeutics US | Meals · 2025-03-26 | Tarpeyo | $125 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-14 | Kerendia | $20 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-21 | Kerendia | $29 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-25 | Kerendia | $30 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $944
| Ardelyx | Xphozah 30 Mg | $240 | 2 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $165 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $142 | 6 payments
|
| Novartis Pharmaceuticals | None | $137 | 4 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $119 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $84 | 3 payments
|
| OPKO Pharmaceuticals | Rayaldee | $25 | 1 payment
|
| Travere Therapeutics | None | $17 | 1 payment
|
| Vifor Pharma | None | $14 | 1 payment
|
2023: $691
| Aurinia Pharma U.S. | Lupkynis | $301 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $237 | 7 payments
|
| GlaxoSmithKline | Benlysta | $150 | 4 payments
|
| Travere Therapeutics | None | $3 | 1 payment
|
2022: $384
| AstraZeneca Pharmaceuticals LP | Lokelma | $122 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $120 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $120 | 1 payment
|
| Amgen | Parsabiv | $22 | 1 payment
|
2021: $636
| Aurinia Pharma U.S. | Lupkynis | $374 | 3 payments
|
| GlaxoSmithKline | Benlysta | $123 | 1 payment
|
| Vifor Pharma | Veltassa | $114 | 5 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $25 | 1 payment
|
2020: $125
| AstraZeneca Pharmaceuticals LP | Lokelma | $125 | 1 payment
|
2019: $399
| AstraZeneca Pharmaceuticals LP | Lokelma | $124 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $120 | 1 payment
|
| Alexion Pharmaceuticals | Soliris | $100 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $56 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 89.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1336569300
- Licence
- CA 20A15461, OH 58.006051
- Trained
- Arizona College of Osteopathic Medicine Mid Western University, 2014 · 12 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 3300 E South St Ste 308, Lakewood, CA, 90805
- NPI first listed
- 2014-04-17
- NPI last updated
- 2025-02-20
- NPI record certified
- 2025-02-20
This is when the NPI record was last certified, not a medical board exam.